The NIH Common Fund/Roadmap Epigenomics Program: Successes of a comprehensive consortium.

Clicks: 319
ID: 43304
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #21 of 64 articles by views in Science advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The NIH Roadmap Epigenomics Program was launched to deliver reference epigenomic data from human tissues and cells, develop tools and methods for analyzing the epigenome, discover novel epigenetic marks, develop methods to manipulate the epigenome, and determine epigenetic contributions to diverse human diseases. Here, we comment on the outcomes from this program: the scientific contributions made possible by a consortium approach and the challenges, benefits, and lessons learned from this group science effort.
Reference Key
satterlee2019thescience Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Satterlee, John S;Chadwick, Lisa H;Tyson, Frederick L;McAllister, Kim;Beaver, Jill;Birnbaum, Linda;Volkow, Nora D;Wilder, Elizabeth L;Anderson, James M;Roy, Ananda L;
Journal Science advances
Year 2019
DOI
10.1126/sciadv.aaw6507
URL
Keywords
garc data logger rabies epidemiological bulletin rabies vaccination tracker rabies strategic dog vaccination

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.